... One study analyzed lurbinectedin (sold under the brand name Zepzelca) in people with relapsed small cell lung cancer. People taking the drug had fewer side effects than those using a traditional treatment plan but didn’t have better outcomes. According to Dr. ...
Posted 10/22/2021